Sildenafil Citrate Tablet, Film Coated
Product Images NDC 60290-079

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 60290-079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Umedica Laboratories Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Sildenafil Citrate 100 mg 1000s)

Sildenafil Tablets USP 100 mg film-coated oral tablets label by Umedica Laboratories USA Inc. The label states the active ingredient as Sildenafil citrate equivalent to 100 mg Sildenafil per tablet. It includes storage instructions at 25°C with permitted excursions, dispensing instructions, dosage reference, and manufacturing details from Umedica Laboratories Pvt. Ltd. in India, distributed by Umedica Laboratories USA Inc. The package contains 1000 tablets.*

FDA Label Image

Image Description (Sildenafil Citrate 100 mg 100s)

Label for Sildenafil Tablets, USP 100 mg by Umedica Laboratories USA Inc. The label indicates the product is a prescription film-coated tablet, containing 100 mg of sildenafil citrate per tablet. The package contains 100 tablets. Manufacturing and distribution details note Umedica Laboratories Pvt. Ltd. in India and Umedica Laboratories USA Inc. in New Jersey, USA. Storage instructions and regulatory information are also present.*

FDA Label Image

Image Description (Sildenafil Citrate 100 mg 30s)

Sildenafil Tablets, USP 100 mg film-coated oral tablets label. Contains Sildenafil citrate equivalent to 100 mg Sildenafil. Pack size is 30 tablets. Manufactured by Umedica Laboratories Pvt. Ltd., India, and distributed by Umedica Laboratories USA Inc. Storage instructions and dosage information references are included. Bar code and product identification numbers are visible.*

FDA Label Image

Image Description (Sildenafil Citrate 25 mg 1000s)

Label for Sildenafil Tablets, USP 25 mg film-coated tablets, containing sildenafil citrate equivalent to 25 mg sildenafil. Distributed in a package of 1000 tablets by Umedica Laboratories USA Inc. The label includes storage instructions (store at 25°C with permitted excursions), manufacturer details (Umedica Laboratories Pvt. Ltd., India), and a barcode. It also notes the product is prescription only (Rx only) and child-resistant packaging is used.*

FDA Label Image

Image Description (Sildenafil Citrate 25 mg 30s)

Sildenafil Tablets USP 25 mg film-coated tablets packaging label. The label indicates the product contains 25 mg of sildenafil citrate per tablet. The label includes the NDC number 60290-079-01, is manufactured by Umedica Laboratories Pvt. Ltd., India, and distributed by Umedica Laboratories USA Inc. The package contains 30 tablets and is marked Rx only.*

FDA Label Image

Image Description (Sildenafil Citrate 50 mg 1000s)

Label for Sildenafil Tablets, USP 50 mg film-coated tablets, distributed by Umedica Laboratories USA Inc. The label includes storage instructions (25°C with excursions permitted within 15-30°C), NDC 60290-002-03, and states the package contains 1000 tablets. Manufactured by Umedica Laboratories Pvt. Ltd., India, with barcode and product identification codes visible.*

FDA Label Image

Image Description (Sildenafil Citrate 50 mg 30s)

Sildenafil Tablets USP 50 mg film-coated tablets label from Umedica Laboratories USA Inc. The label states the product contains 50 mg sildenafil citrate per tablet and is supplied in a package of 30 tablets. It includes storage instructions, manufacturing and distribution information, a barcode, and references a medication guide link.*

FDA Label Image

Sildenafil-citrate-figure-1 (Sildenafil Citrate Figure 1)

Line graph depicting the change in systolic blood pressure (mmHg) over time (hours) post-dose for Sildenafil 100 mg compared to placebo. The x-axis represents time up to 24 hours, and the y-axis shows systolic blood pressure changes. Two lines with different markers illustrate the blood pressure trends for the drug and placebo groups.*

FDA Label Image

Sildenafil-citrate-figure-2 (Sildenafil Citrate Figure 2)

A line graph depicting the change in systolic blood pressure (SBP) in mmHg over time postdose (hours). It compares two treatments: Doxazosin with placebo and Doxazosin with Sildenafil 25 mg, showing variations in SBP change from 0 to 8 hours after dosing.*

FDA Label Image

Sildenafil-citrate-figure-3 (Sildenafil Citrate Figure 3)

A line graph depicting the change in systolic blood pressure (SBP) over time postdose in hours up to 8 hours. The graph compares two treatments: Doxazosin plus Placebo and Doxazosin plus Sildenafil 50 mg, showing their respective trends in SBP change.*

FDA Label Image

Sildenafil-citrate-figure-4 (Sildenafil Citrate Figure 4)

A line graph showing the effect on mmHg over time in hours after dosing with two treatments: Doxazosin plus Sildenafil 100 mg and Doxazosin plus placebo. The vertical axis represents mmHg values ranging from -50 to 40, and the horizontal axis shows time from 0 to 8 hours post-dose. The plot compares blood pressure changes over time between the two treatments.*

FDA Label Image

Sildenafil-citrate-figure-5 (Sildenafil Citrate Figure 5)

A line graph showing plasma concentrations (ng/ml) of sildenafil citrate over time (hours) post dose. The graph depicts plasma levels rising sharply to a peak between 1 and 2 hours, followed by a gradual decline to near zero by 24 hours after taking a commercial tablet dosage form.*

FDA Label Image

Sildenafil-citrate-figure-6 (Sildenafil Citrate Figure 6)

Two bar charts displaying the effect of sildenafil citrate and placebo on the maintenance of erection by baseline score. The x-axis shows baseline scores from 0 to 5, and the y-axis represents the percentage of patients at endpoint from 0 to 80%. Each bar cluster is divided by different score levels (0-5) as indicated in the legend. The top chart represents sildenafil citrate, and the bottom chart represents placebo.*

FDA Label Image

Sildenafil-citrate-figure-7 (Sildenafil Citrate Figure 7)

A vertical bar chart comparing the percentage of patients reporting improvement across treatment groups for Sildenafil citrate oral tablets in dosages 25 mg, 50 mg, and 100 mg versus placebo. The percentages are 24% for placebo, 63% for 25 mg, 74% for 50 mg, and 82% for 100 mg, with sample sizes noted below each bar. The chart indicates overall treatment efficacy with a p-value less than 0.0001.*

FDA Label Image

Sildenafil-citrate-structure (Sildenafil Citrate Structure)

Chemical structure of the active ingredient Sildenafil Citrate, showing its molecular formula with rings, functional groups including sulfonamide, piperazine, and citrate components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.